Investor Relations

We are a medical technology company focused on the design, development and commercialization of glucose monitoring systems to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy.

Upcoming Events

Raymond James 38th Annual Institutional Investors Conference
Senseonics’ management is scheduled to present Monday, March 6, 2017 at 3:00 p.m. EST
View All Events

Share Price

Stock Information

Investor Alerts

Sign up to receive email alerts.